Cargando…

Cardiovascular molecular mechanisms of disease with COVID-19

Detalles Bibliográficos
Autores principales:	Foo, Roger, Wang, Yibin, Zimmermann, Wolfram-Hubertus, Backs, Johannes, Wang, Dao Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151487/ https://www.ncbi.nlm.nih.gov/pubmed/32289321 http://dx.doi.org/10.1016/j.yjmcc.2020.04.010

Ejemplares similares

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
por: Nishiga, Masataka, et al.
Publicado: (2020)

Regulation of CaMKII signaling in cardiovascular disease
por: Mollova, Mariya Y., et al.
Publicado: (2015)

COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations
por: Shu, Hongyang, et al.
Publicado: (2023)

Using “old” medications to fight new COVID-19: Re-purposing with a purpose
por: Wang, Yibin, et al.
Publicado: (2020)

Integrated mechanisms of CaMKII-dependent ventricular remodeling
por: Kreusser, Michael M., et al.
Publicado: (2014)

Biomechanical regulation of in vitro cardiogenesis for tissue-engineered heart repair
por: Zimmermann, Wolfram-Hubertus
Publicado: (2013)

Cardiac Tissue Engineering: Implications for Pediatric Heart Surgery
por: Zimmermann, Wolfram-Hubertus, et al.
Publicado: (2009)

Cell programming to protect the ischemic heart and limb
por: Brittan, Mairi, et al.
Publicado: (2021)

The potential effects of DPP‐4 inhibitors on cardiovascular system in COVID‐19 patients
por: Du, Hengzhi, et al.
Publicado: (2020)

Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities
por: Wang, James Jiqi, et al.
Publicado: (2020)

COVID-19 and cardiovascular diseases
por: Liu, Fan, et al.
Publicado: (2020)

Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug
por: Li, Qianqian, et al.
Publicado: (2020)

Prenatal Stress: Molecular Mechanisms and Cardiovascular Disease
por: Cezar, Marcelo Diarcadia Mariano, et al.
Publicado: (2019)

Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease
por: Xie, Lai-Hua, et al.
Publicado: (2022)

Cardiovascular Involvement in Patients with 2019 Novel Coronavirus Disease
por: Li, Chenze, et al.
Publicado: (2021)

Cardiovascular Disease and Exercise: From Molecular Mechanisms to Clinical Applications
por: Wang, Bo, et al.
Publicado: (2022)

Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease
por: Li, Anqi, et al.
Publicado: (2022)

Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
por: Ke, Liang-Yin, et al.
Publicado: (2020)

RCAN1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target
por: Wang, Shuai, et al.
Publicado: (2020)

Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseases
por: Paluvai, Harikrishnareddy, et al.
Publicado: (2023)

Mechanisms of thrombosis and cardiovascular complications in COVID-19
por: Page, Eden M., et al.
Publicado: (2021)

Saving critically ill COVID-19 patients with mechanical circulatory support
por: Li, Rui, et al.
Publicado: (2021)

The role of CD36 in cardiovascular disease
por: Shu, Hongyang, et al.
Publicado: (2020)

Emerging Roles of Ceramide in Cardiovascular Diseases
por: Shu, Hongyang, et al.
Publicado: (2022)

Cardiovascular disease and COVID-19
por: Bansal, Manish
Publicado: (2020)

Generation of Engineered Human Myocardium in a Multi-well Format
por: Tiburcy, Malte, et al.
Publicado: (2020)

Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis
por: Seeherman, Sarah, et al.
Publicado: (2021)

Cardiovascular Manifestations and Mechanisms in Patients with COVID-19
por: Dou, Qingyu, et al.
Publicado: (2020)

The molecular mechanisms in prenatal drug exposure-induced fetal programmed adult cardiovascular disease
por: Wu, Ting, et al.
Publicado: (2023)

Molecular Mechanism Underlying Role of the XBP1s in Cardiovascular Diseases
por: Liu, Shu, et al.
Publicado: (2022)

Protective effects and molecular mechanisms of tea polyphenols on cardiovascular diseases
por: Guo, Jun, et al.
Publicado: (2023)

Cardiac injuries in coronavirus disease 2019 (COVID-19)
por: Chen, Chen, et al.
Publicado: (2020)

Food Insecurity and Cardiovascular Disease Risk
por: Liu, Yibin, et al.
Publicado: (2021)

COVID-19 and cardiovascular diseases
por: Mai, Francesca, et al.
Publicado: (2020)

COVID-19 and cardiovascular disease
por: Guijarro, Carlos
Publicado: (2020)

Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases
por: Thankam, Finosh G., et al.
Publicado: (2021)

Immunological Properties of Murine Parthenogenetic Stem Cell-Derived Cardiomyocytes and Engineered Heart Muscle
por: Didié, Michael, et al.
Publicado: (2017)

Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets
por: Poller, Wolfgang, et al.
Publicado: (2023)

Ongoing controversies surrounding cardiac remodeling: is it black and white—or rather fifty shades of gray?
por: Spaich, Sebastian, et al.
Publicado: (2015)

Susceptibility and prognosis of COVID-19 patients with cardiovascular disease
por: Wang, Brian Xiangzhi
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_32aev3hjuc5uqtikjifj29umh7